택사 (澤瀉, Alismatis Rhizoma) 추출물이 RBL-2H3 비만세포와 OVA/alum 감작 생쥐의 알레르기 염증 반응에 미치는 영향
The Effects of Alismatis Rhizoma Extract on Allergic Inflammation in RBL-2H3 Mast Cells and OVA/alum-Sensitized Mice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives Alismatis Rhizoma has been known to suppress inflammation and allergic reaction. However, the cellular target of Alismatis Rhizoma and its mechanism of action remain unclear. This study was designed to examine the effect of Alismatis Rhizoma extract (ALC) on the RBL-2H3 mast cells in vitro and on the OVA/alum sensitized mice ex vivo. Methods In the study, RBL-2H3 mast cells were cultured in minimal essential medium (MEM) for 24 hours, and treated separately with cyclosporin A and varying doses of ALC, and then stimulated with Phorbol 12-myristate 13-acetate (PMA) (50 ng/㎖) and Ionomycin (0.5 μM). The levels of IL-13, IL-4 were measured by ELISA analysis. The mRNA levels of IL-4, IL-5, IL-6, IL-13, GM-CSF, TNF-α were analyzed with Real-time PCR. Also, manifestations of MAPKs transcription factors and NF-κB p65 translocation were analyzed by western blotting in vitro. Subsequently, for ex vivo experiment, we induced allergic inflammation on Balb/c mice by OVA/alum and administered ALC orally. And we measured serum OVA-specific IgE level and IL-4, IL-13 in the splenocyte culture supernatant by ELISA analysis. Results ALC was shown to suppress mRNA expression of IL-4, IL-5, IL-6, IL-13, GM-CSF, TNF-α, and to inhibit the IL-13, IL-4 production. Also ALC reduced an activation of mast cells specific signal MAPKs transcription factors and NF-κB p65 from the western blot analysis in in vitro experiment. In ex vivo, ALC oral adminstration decreased the level of OVA-specific IgE in serum, and IL-4, IL-13 in the splenocyte culture supernatant. Conclusions ALC is shown to reduce inflammation and allergic response by suppressing Th2 cytokines through the regulation of transcription factors MAPKs and NF-κB p65 in mast cells. Administration of ALC suppressed OVA-specific IgE in ovalbumin allergy model through the inhibition of Th2 cytokine. In conclusion, ALC can be considered as an effective treatment for allergic diseases such as atopic dermatitis.
Abstract
Objectives Alismatis Rhizoma has been known to suppress inflammation and allergic reaction. However, the cellular target of Alismatis Rhizoma and its mechanism of action remain unclear. This study was designed to examine the effect of Alismatis Rhizoma extract (ALC) on the RBL-2H3 mast cells in vitro and on the OVA/alum sensitized mice ex vivo. Methods In the study, RBL-2H3 mast cells were cultured in minimal essential medium (MEM) for 24 hours, and treated separately with cyclosporin A and varying doses of ALC, and then stimulated with Phorbol 12-myristate 13-acetate (PMA) (50 ng/㎖) and Ionomycin (0.5 μM). The levels of IL-13, IL-4 were measured by ELISA analysis. The mRNA levels of IL-4, IL-5, IL-6, IL-13, GM-CSF, TNF-α were analyzed with Real-time PCR. Also, manifestations of MAPKs transcription factors and NF-κB p65 translocation were analyzed by western blotting in vitro. Subsequently, for ex vivo experiment, we induced allergic inflammation on Balb/c mice by OVA/alum and administered ALC orally. And we measured serum OVA-specific IgE level and IL-4, IL-13 in the splenocyte culture supernatant by ELISA analysis. Results ALC was shown to suppress mRNA expression of IL-4, IL-5, IL-6, IL-13, GM-CSF, TNF-α, and to inhibit the IL-13, IL-4 production. Also ALC reduced an activation of mast cells specific signal MAPKs transcription factors and NF-κB p65 from the western blot analysis in in vitro experiment. In ex vivo, ALC oral adminstration decreased the level of OVA-specific IgE in serum, and IL-4, IL-13 in the splenocyte culture supernatant. Conclusions ALC is shown to reduce inflammation and allergic response by suppressing Th2 cytokines through the regulation of transcription factors MAPKs and NF-κB p65 in mast cells. Administration of ALC suppressed OVA-specific IgE in ovalbumin allergy model through the inhibition of Th2 cytokine. In conclusion, ALC can be considered as an effective treatment for allergic diseases such as atopic dermatitis.
참고문헌 (34)
- Pediatric Allergy, "Korean academy of pediatric allergy and respiratory disease", pp.51~92 (2013), Ryo Moon Gak
- Ahn HS, "Hong Changui Pediatrics", pp.1241~1242 (2016), Mirae N
- Ma SY, "Hyeondae Chinese medicine dermatology & venereology", pp.153~160 (2001)
- Cha KB, "Literatual study on atopic dermatitis", J Daejeon Univ Institut Korean Med, 14(2), pp.113~126 (2005)
- Korea Institute of Oriental Medicine, "Atopic dermatitis Korean medicine clinical practice guideline", pp.30~ (2015), Elsevier Korea L.L.C.
- Hong NM, "A literature study about comparison of Eastern-Western medicine on the atopic dermatitis", J Orient Med Surg Ophthalmol Otolaryngol, 12(1), pp.241~253 (1999)
- Ju YS, "Ungok Herbology", pp.714~717 (2013), Woosuk Press
- Heo J, "Donguibogam", pp.2727~ (1994), Ryo Gang
- Choi IH, "The effect of TJ-15 plus TJ-17 on atopic dermatitis: a pilot study based on the principle of pattern identification", J Altern Complement Med, 18(6), pp.576~582 (2012)[DOI]
- 최인화, "Non-comparative Study for the Observation of Clinical Efficacy and Safety of CheungYeolYiSeup-tang and Hwangbaek External dressings on Dampness-Heat Pattern Atopic Dermatitis", 대한한의학회지, 29(5), pp.41~51 (2008), 대한한의학회
- Huang YT, "Alisol B acetate, a triterpene from Alismatis rhizoma, induces Bax nuclear translocation and apoptosis in human hormone-resistant prostate cancer PC-3 cells", Cancer Lett, 231(2), pp.270~278 (2006)[DOI]
- 박종철, "택사 메탄올 추출물과 주성분의 항산화작용", 생약학회지, 38(4), pp.372~375 (2007), 한국생약학회
- Lin HR, "Triterpenes from Alisma orientalis act as farnesoid X receptor agonists", Bioorg Med Chem Lett, 22(14), pp.4787~4792 (2012)[DOI]
- Park YJ, "Ethanol extract of Alismatis rhizome inhibits adipocyte differentiation of OP9 cells", Evid Based Complement Alternat Med, pp.415097~ (2014)
- Matsuda H, "Effects of sesquiterpenes and triterpenes from the rhizome of Alisma orientale on nitric oxide production in lipopolysaccharide-activated macro- phages: absolute stereostructures of alismaketones-B 23-acetate and -C 23-acetate", Bioorg Med Chem Lett, 9(21), pp.3081~3086 (1999)[DOI]
- Han CW, "Ethanol extract of Alismatis Rhizoma reduces acute lung inflammation by suppressing <TEX>$NF-{\kappa}B$<", TEX> and activating Nrf2, 2013, pp.146(1), 402~410
- Kim NY, "In vitro inducible nitric oxide synthesis inhibitors from Alismatis Rhizoma", Biol Pharm Bull, 22(10), pp.1147~1149 (1999)[DOI]
- Lee JH, "The rhizomes of Alisma orientale and alisol derivatives inhibit allergic response and experimental atopic dermatitis", Biol Pharm Bull, 35(9), pp.1581~1587 (2012)[DOI]
- Kubo M, "Studies on Alismatis rhizoma. I. Anti-allergic effects of methanol extract and six terpene components from Alismatis rhizoma (dried rhizome of Alisma orientale)", Biol Pharm Bull, 20(5), pp.511~516 (1997)[DOI]
- Matsunaga MC, "IL-4 and IL-13 inhibition in atopic dermatitis", J Drugs Dermatol, 15(8), pp.925~929 (2016)
- Ishiyama M, "A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability", Talanta, 44(7), pp.1299~1305 (1997)[DOI]
- 김계하, "우리나라 성인의 아토피피부염 관련요인: 2008년도 국민건강영양조사 자료를 중심으로", 재활간호학회지, 15(2), pp.83~90 (2012), 한국재활간호학회[DOI]
- Korea national health and nutrition examination survey (KNHANES VII-1), "Korea Health Statistics", ~ (2016)
- Katayama I, "Japanese guidelines for atopic dermatitis 2017", Allergol Int, 66(2), pp.230~247 (2017)[DOI]
- Guglielmetti S, "Atopic keratoconjunctivitis and atopic dermatitis", Curr Opin Allergy Clin Immunol, 10(5), pp.478~485 (2010)[DOI]
- 이진용, "Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea", Annals of Dermatology, 27(5), pp.499~506 (2015), 대한피부과학회
- Novak N, "Immune mechanisms leading to atopic dermatitis", J Allergy Clin Immunol, 112(6 Suppl), pp.S128~S139 (2003)[DOI]
- 김민아, "신선초 추출물의 아토피 억제활성", Food Science and Preservation, 19(5), pp.792~798 (2012), 한국식품저장유통학회
- Shin MG, "Clinical traditional herbalogy", pp.657~658 (2000), Yeong Lim
- Park JH, "Plasma histamine levels in patients with atopic dermatitis", Korean J Dermatol, 37(11), pp.1553~1559 (1999)
- Erb KJ, "Helminths, allergic disorders and IgE-mediated immune responses: where do we stand?", Eur J Immunol, 37(5), pp.1170~1173 (2007)[DOI]
- de Mora F, "The role of mast cells in atopy: what can we learn from canine models? a thorough review of the biology of mast cells in canine and human systems", Br J Dermatol, 155(6), pp.1109~1123 (2006)[DOI]
- 노효선, "비만세포에서 백질려 추출물의 항염증효과에 대한 연구", 대한본초학회지, 32(2), pp.107~114 (2017), 대한본초학회[DOI]
- Baeuerle PA, "NF-kappa B: ten years after", Cell, 87(1), pp.13~20 (1996)[DOI]